CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 



Enzo Biochem Inc  (ENZ)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
 
 

Enzo Biochem Inc Growth Comparisons

Select each growth Category to receive further Information

Select the Comparisons : Select the Ratio:                        

ENZ Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q1 MRQ) 2.48 % 20.31 % -1.56 % 5.92 %
Q / Q Revenue Growth (Q1 MRQ) 3.16 % 123.18 % 1.71 % -4.7 %
Y / Y Revenue Growth (for 12 months ending Q1 TTM) 4.29 % 1.56 % 1.76 % %
Seq. Revenue Growth (for 12 months ending Q1 TTM) 0.62 % 0.74 % -0.67 % 2.35 %
Revenue 5 Year Average Growth - 11.69 % 9.82 % 14.44 %
Expected Revenue Growth (Y/Y) - - 1.89 % 2.71 %


ENZ's Growth Comparisons in III. Quarter 2017


You need to upgrade your Flash Player


Enzo Biochem Inc's Revenue slowed to the 2.48% year on year, improvement in the third quarter 2017 to 27 millions, underperforming the 20.31% improvement in Medical Laboratories industry, but beating the -1.56% decrease in the Healthcare sector. Comparing third quarter sales, Enzo Biochem Inc was trailing overall market not just Medical Laboratories industry.

Comparing company's Revenue to the second quarter results, sales were higher by 3.16% . On the yearly basis, average annual sales growth for Enzo Biochem Inc is %, while S & P 500's including only Businesses with the third quarter 2017 earnings, average annual sales growth is 14.44% over the past five years.


Growth Rates of ENZ's Income in the third quarter 2017


ENZ Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q1 MRQ) - -19.08 % -0.58 % 32.7 %
Seq. Operating Income Change (Q1 MRQ) - 3979.27 % 44.7 % 9.17 %
Y / Y Operating Income Growth (Q1 TTM) 92.06 % -10.85 % 6.98 % 26.47 %
Seq. Operating Income Growth (Q1 TTM) 7.01 % -6.77 % -1.96 % 22.26 %
Operating Income 5 Year Avg. Change - 3.31 % -0.84 % 13.42 %

Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q1 MRQ) - - -8.93 % 24.97 %
Seq. Income from Cont. Ops. Change (Q1 MRQ) - - 122.86 % 20.34 %
Y / Y Income from Cont. Ops. Change (Q1 TTM) 90.63 % -10.19 % -12.1 % 9.63 %
Seq. Income from Cont. Ops. Change (Q1 TTM) 6.49 % -11.31 % -6.64 % 6.18 %
Income from Cont. Ops. 5 Year Avg. Change - -6.83 % 1.3 % 15.81 %

ENZ Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q1 MRQ) - - -10.93 % 19.85 %
Q / Q Net Income Growth (Q1 MRQ) - - 100.2 % 15.8 %
Y / Y Net Income Change (Q1 TTM) 90.63 % -30.03 % 1.15 % 11.3 %
Seq. Net Income Change (Q1 TTM) 6.49 % -13.93 % -6.21 % 5.16 %
Net Income 5 Year Avg. Growth - -6.61 % 4.52 % 15.79 %

ENZ's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q1 MRQ) - - -8.93 % 24.97 %
Seq. EPS from Cont. Ops. Change (Q1 MRQ) - - 122.86 % 20.34 %
Y / Y EPS from Cont. Ops. Change (Q1 TTM) 90.73 % - - -
Seq. EPS from Cont. Ops. Change (Q1 TTM) 7.34 % 50.85 % - 7.54 %
EPS from Cont. Ops. 5 Year Avg. Growth - -32.28 % 1.3 % 15.81 %

You need to upgrade your Flash Player

ENZ EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q1 MRQ) - - -10.93 % 15.81 %
Q / Q EPS Net Growth (Q1 MRQ) - - 100.2 % 15.8 %
Y / Y EPS Net Change (for 12 months ending Q1 TTM) - - - 19.43 %
Seq. EPS Net Change (for 12 months ending Q1 TTM) 7.57 % - - 7.35 %
EPS Net 5 Year Avg. Change - -6.61 % 4.52 % 15.79 %
Expected EPS Growth (Y/Y) - - 123.59 % 29.33 %



Enzo Biochem Inc reported bottom-line of $ 0.00 in the third quarter, compare to $ -0.05 in the same quarter a year ago. Medical Laboratories industry grew by 20.31%, while Healthcare sector decreased by -10.93%, and overall market improved by 19.85%.

Comparing company's EPS to the second quarter results, income per share were higher by 3.16% . On the yearly basis, average annual income per share growth for Enzo Biochem Inc is %, while S & P 500's including only Businesses with the third quarter 2017 Results, average annual income per share growth is 15.79% over the past five years.

ENZ Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q1 MRQ) - -41.13 % 14.6 % 1.59 %
Seq. Free Cash Flow Change (Q1 MRQ) - -79.97 % -31.38 % -48.92 %
Y / Y Free Cash Flow Change (Q1 TTM) 70.65 % 45.3 % 8.17 % -0.08 %
Seq. Free Cash Flow Change (Q1 TTM) 14.99 % -1.9 % -1.45 % -3.82 %
Free Cash Flow 5 Year Avg. Change - 6.15 % 5.22 % 16.16 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q1 MRQ) - - - -25.65 %
Seq. Net Cash Flow Change (Q1 MRQ) - - -81.01 % -
Y / Y Net Cash Flow Change (Q1 TTM) 68.29 % - 200.73 % -3.75 %
Seq. Net Cash Flow Change (Q1 TTM) - - 70.37 % -14.2 %
Net Cash Flow 5 Year Avg. Change - - -17.31 % 34.83 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q1 MRQ) 64.8 % 30.14 % 19.25 % 0.88 %
Seq. Capital Expenditures Change (Q1 MRQ) 320 % -27.6 % -32.71 % -37.39 %
Y / Y Capital Expenditures Change (Q1 TTM) -21.91 % 31.16 % 11.83 % -1.42 %
Seq. Capital Expenditures Change (Q1 TTM) 22.65 % 4.67 % 2.87 % -3.67 %
Capital Expenditures 5 Year Avg. Change - - -73.95 % -67.93 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com